Chaperonin Protein CCT2 Emerges as Key Driver of Aggressive Head and Neck Cancer and Cisplatin Resistance
New research shows that the chaperonin subunit CCT2 stabilizes the oncoprotein c-Myc to drive head and neck squamous cell carcinoma ...
New research shows that the chaperonin subunit CCT2 stabilizes the oncoprotein c-Myc to drive head and neck squamous cell carcinoma ...
New research reveals that the secreted protein DKK1 helps oral squamous cell carcinoma resist cisplatin by keeping the SLC3A2 cystine ...
Researchers at Chongqing Medical University report that hypoxia silences the tumor suppressor CCNDBP1 in cervical cancer, activating a USP11–Nrf2 antioxidant ...
A systematic review of 66 zinc(II) Schiff base complexes shows that octahedral geometry and red-shifted imine infrared signatures predict potent, ...
A new study shows that the transcription factor ELF4 activates the enzyme UGT8, reshaping sphingolipid metabolism to drive esophageal squamous ...
A new study shows that mutations emerging in the ENPP1 gene during treatment drive cisplatin resistance and recurrence in hypopharyngeal ...
New research links the SERPINE1–CA9 gene axis to both aggressive growth and cisplatin resistance in head and neck squamous cell ...
Engineered platinum-manganese nanodendrites activated by ultrasound concurrently trigger ferroptosis and PANoptosis, overcoming cisplatin resistance in breast cancer models.
In a groundbreaking advance that could revolutionize the treatment landscape for ovarian cancer, researchers have unveiled compelling evidence that the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine